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Abstract
Insulin-Degrading-Enzyme (IDE) is a Zn2+-dependent peptidase highly conserved through-
out evolution and ubiquitously distributed in mammalian tissues wherein it displays a preva-
lent cytosolic localization. We have recently demonstrated a novel Heat Shock Protein-like
behaviour of IDE and its association with the 26S proteasome. In the present study, we
examine the mechanistic and molecular features of IDE-26S proteasome interaction in a
cell experimental model, extending the investigation also to the effect of IDE on the enzy-
matic activities of the 26S proteasome. Further, kinetic investigations indicate that the 26S
proteasome activity undergoes a functional modulation by IDE through an extra-catalytic
mechanism. The IDE-26S proteasome interaction was analyzed during the Heat Shock
Response and we report novel findings on IDE intracellular distribution that might be of
critical relevance for cell metabolism.
Introduction
Insulin-Degrading Enzyme (IDE) is an evolutionarily conserved 110-kDa zinc metallo-peptidase
which belongs to the “Invertzincin” family (M16) of metallo-enzymes [1,2]. In mammalian tis-
sues IDE expression is ubiquitous and the enzyme displays a wide sub-cellular distribution: it is
found in the cytosol, endosomes, peroxisomes and a small fraction is further located on plasma
membrane and mitochondria [3–7].
Several studies have shown that IDE efficiently degrades insulin, glucagon, beta-amyloid
and, in general, peptides that share amyloidogenic propensity [8,9]. In this context, a role of
IDE in dys-metabolic (i.e., type 2 Diabetes Mellitus) and neurodegenerative (i.e., Alzheimer’s
Disease) disorders has been envisaged [10–13]. However, the biological properties of the
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enzyme raise in vivo some unresolved questions, since a pivotal role in insulin catabolism likely
does not account for the relative abundance of IDE in tissues wherein glucose uptake is poorly
affected by the hormone. Furthermore, it is still matter of debate whether the degradation of
those natural substrates identified thus far [8–13] indeed reflects IDE main physiological role,
since the enzyme is mainly located in cell compartments where the occurrence of anabolic and
catabolic processes of these substrates is still matter of debate [14]. Hence, there is a compelling
evidence that IDE could play additional roles not fully characterized yet. In this respect, it must
be outlined that a plethora of intriguing observations (such as the widespread up-regulation of
IDE in human tumors, the interaction with some onco-suppressors and with monomeric ubi-
quitin) demands deeper considerations on the interactome of IDE in the intracellular compart-
ment [6,15–23]. As a matter of fact, we have recently published a paper whereby we proposed
the enzyme as a novel Heat Shock-like Protein (HSP) [22], demonstrating that (i) in SHSY5Y
cells IDE co-immunoprecipitates with the 26S proteasome and (ii) modulation of IDE expres-
sion influences the Ubiquitin-Proteasome System (UPS), affecting neuroblastoma cell prolifer-
ation and viability.
The 26S proteasome is the multi-subunit component of the Ubiquitin-Proteasome System
which provides the machinery for the degradation of the vast majority of intracellular proteins,
hence regulating the quality control and every aspect of cell life, as now widely recognized [24–
28]. It is composed by one or two Regulatory Particles (RP), called 19S (MW ~900 kDa), which
associate with a Core Particle (CP), named 20S (MW ~650 kDa), where the proteolytic activi-
ties reside [29,30]. From the structural viewpoint, the 19S RP is made by several subunits
which self-assemble in the course of an ordered maturation process into two main complexes:
the lid and the base [31]. On the other hand, the 20S CP has a cylindrical shape and it is com-
posed by four-stacked rings with different specificities whose hierarchical assembly shapes a
narrow channel through which the substrate is addressed for catalysis [32]. The two outer
α-rings are made by seven structurally similar subunits, named alpha1–7, whose N-termini
strictly regulate pore gating. The two inner rings are made by seven beta subunits, named
beta1–7, where the active sites for the three identified catalytic activities are located [32–34];
more specifically, the caspase-like, the tryptic-like and the chymotryptic-like activities are asso-
ciated with the beta1 (PSMB1), beta2 (PSMB2) and beta5 (PSMB5)subunits, respectively [24].
Gate-opening and substrate selection are tightly regulated processes which occur through
structural and conformational interactions between the 19S and the 20S particles [34]. The
most studied activity of the 26S proteasome is that on poly-ubiquitinated substrates: the Ubi-
quitin-Conjugation System (UCS) selectively tags the target protein with a poly-ubiquitin
chain of variable length which is then recognized by the RP. The detachment of ubiquitin moi-
eties and denaturation of the protein precede its translocation into the proteasome catalytic
chamber where the three activities generate peptides ranging from 3 to 20 residues [35,36].
Substrates undergoing proteolytic cleavage and fragmentation are not only Ub-tagged proteins,
since also damaged and oxidized proteins can be degraded by the proteasome machinery
regardless of the Ub-label [37,38].
It is worth pointing out that the emerging aspects on proteasome biology concern the co-
existence of a highly heterogeneous population of proteasome particles that might be distin-
guished on the basis of their subunit composition as well as of their sub-cellular localization.
Besides the 19S RP, alternative regulatory particles have been identified (e.g., PA28) and alter-
native catalytic subunits have been documented, being characterized by distinct substrate spec-
ificities and proteolytic properties (e.g., the immuno-proteasome) [39–42]. It is reasonable that
additional not yet identified regulatory particles might exist. Their assembly with the CP could
give rise to different complexes characterized by a precise biological function. Moreover, a myr-
iad of molecular factors and a wide range of post-translational modifications modulate the
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assembly, the catalytic properties and the qualitative and quantitative range of substrates
undergoing degradation by the proteasome [24,43–47].
In this paper, starting from the evidence that IDE and the 26S proteasome co-immunopre-
cipitate [22,48,49], we investigate such a tight interaction through cellular and biochemical
approaches. Further, we provide the first characterization of the functional properties of the
cytosolic pool of the 26S proteasome during 24 hr of recovery after heat stress exposure, formu-
lating a proposal for the putative role of IDE in the observed behaviour. Notably, novel intrigu-
ing insights on IDE biological features during the HSR are discussed.
Materials and Methods
IDE-silencing experiments
Silencing of IDE expression in SHSY5Y cells was achieved through administration of a pool of
Anti-Sense Nucleotide (siRNA) (Dharmacon Lafayette, St. Louis, MO, USA).
Differently from what reported in the previously published paper [22], the final concentra-
tion of the siRNA was adjusted to a sub-lethal concentration (i.e., 0.70 micromol/L instead of
1 micromol/L which was found to be lethal 72 h after the administration) that induced only a
modest decrease of the proliferation rate without interfering with cell viability. In all experi-
ments, Trypan blue exclusion viability test indicated that 96 h after anti-sense oligonucleotide
administration at least 90% of cells was still viable.
Cells were seeded on a Falcon 6-well Plate at a concentration of 1.5 x 104 cells/well in
DMEM supplemented with 10% FBS. On the following day, the medium was removed and the
cell monolayer gently washed twice with pre-warmed PBS before the addition of the transfec-
tion medium (Accell media, supplied by the manufacturer), containing either 0.70 micromol/L
siRNA to IDE or 0.70 micromol/L of a non-targeting siRNA or else the equivalent volume of
the siRNA vector (not specified by the manufacturer).
Cells were then grown in a humidified 5% CO2 incubator and harvested 48 h or 72 h
after anti-sense administration. The cells were then lysed in detergent-free buffer (0.25 mol/L
Sucrose, 0.025 mol/L Hepes, 0.01 mol/L MgCl2, 1 millimol/L EDTA, 1 millimol/L DTT,
2 millimol/L ATP, pH 7.8) through freeze-thaw cycles for preparation of crude cell extracts
[33,46,50]. The soluble fraction containing the 26S proteasome was then “squeezed out”
through centrifugation 30 min at 14,000 rpm at 4°C. Time-course analysis of the 26S protea-
some activity during 24 h of heat-stress recovery was performed by exposing cells for 20 min at
46°C in a thermostated incubator; then, recovery phases occurred under standard conditions
(37°C, 5% CO2). It is worth pointing out that heat stress procedure was made cultivating cells
both in Transwell 6-well Plates and standard cell flasks: the temperature increase of cell culture
medium was monitored and, notably, during the 20 minutes time interval the cell medium
raised the effective 46°C temperature around the 16th minute, thus determining an overall
exposure of cells to 46°C for 4 minutes.
At the indicated different time-points, i.e. before heat-stress was administered (correspond-
ing to time = 0) and after 2 h, 6 h, 12 h and 24 h of recovery cells were harvested as indicated
above. In all cases Trypan blue exclusion viability test indicated that, after stress, at least the
85% of cells was viable over 24 h of recovery.
It must be remarked that in this study SHSY5Y cells were silenced in an insulin-free
medium (according to the manufacturer instructions) and, further, no supplementation with
FBS was made; this procedure was followed to avoid the presence of insulin which was reported
to affect the 26S proteasome activities [48,49].
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Proteasome assay in SHSY5Y cells
Proteasome assay was performed in crude cell extracts from SHSY5Y cells in a 96-well micro-
plate for fluorimetric readings. The fluorescence was detected in an Eclipse fluorimeter (Var-
ian) and the excitation and emission wavelengths were, for all substrates employed, 380 nm
and 460 nm, respectively.
Protein concentration in crude cell extracts was normalized by Bradford assay and (for each
experimental condition) 5 micrograms were incubated in the 26S proteasome activity buffer
(0.05 millimol/L Hepes, pH 7.8, 20 millimol/L KCl, 5 millimol/L MgCl2, 1 millimol/L DTT,
1 millimol/L ATP) with 200 micromol/L of the three different fluorogenic substrates specific
for the 26S proteasome proteolytic activities (i.e., Suc-LLVY-AMC, Boc-LRR-AMC and
Z-LLE-AMC for the chymotryptic-like, tryptic-like and caspase-like activities, respectively)
(Boston Biochem, Boston, USA). Each measurement was done in triplicate and the fluorimetric
reports were then collected every 30 min over 4 h of incubation at 37°C. All buffers contained
Mg2+ and ATP to improve stability of the 26S complex and KCl to reduce the activity of the
20S proteasome pool [47,50].
All the results here reported represent the average data from three different observations on
five independent experiments: each measurement and the relative activities (expressed as a.u.)
reflect the rate of fluorogenic substrate hydrolysis by the 26S proteasome with an extent of
peptide hydrolysis less than 10%. Each measurement was further performed in presence of
10 micromol/L (for chymotryptic-like and caspase-like activities) and 50 micromol/L (for tryp-
tic-like activity) lactacystin in order to distinguish the specific 26S proteasome proteolytic
activity from not specific enzymatic activity. Noteworthy, not specific degradation of the
fluorogenic substrates was essentially negligible for chymotryptic and caspase-like activities,
whereas only a modest tryptic activity not referable to the 26S proteasome was detected
(around 15–20% of the total activity).
Kinetic analysis
The characterization of the 26S proteasome activities (i.e. chymotryptic-like, tryptic-like and
caspase-like) as a function of IDE concentration was carried out through a fluorimetric
approach. All measurements were performed in quartz fluorimeter cuvette.
A highly purified 26S proteasome, extracted from transformed HEK cells (Boston Biochem,
Boston, USA) was diluted to a final concentration of 1 nanomol/L in the assay buffer (Tris-
HCl 20 millimol/L, 10 millimol/L MgCl2, 10% glycerol, 2 millimol/L DTT, 1 millimol/L ATP,
pH 7.8) in the absence and in the presence of different concentrations of a recombinant IDE
expressed in Spodoptera frugiperda (Calbiochem, Merck Biosciences, Darmstadt Germany).
The reaction mixtures were incubated 20 min at 37°C. Then, the fluorogenic substrate (50
micromol/L) specific for each of the three 26S proteasome activities was added. The rate of
hydrolysis of the fluorogenic substrate was monitored for 45 min, a time interval over which
only a small fraction of the substrate underwent proteolysis, and the relative velocities were
extrapolated; during the same time interval, no auto-proteolysis of the substrate was observed.
The relative activities reported throughout the text refer to the ratio between velocities of
the reaction in the absence and in the presence of IDE. The reaction was blocked upon admin-
istration of proteasome specific inhibitors (i.e., 20 micromol/L lactacystin and/or epoxomycin).
Kinetics of Z-LLE-AMC degradation by IDE were determined as follows: the fluorogenic
substrate was incubated in the presence of 30 nanomol/L IDE in the assay buffer (Tris-HCl 20
millimol/L, 10 millimol/L MgCl2, 10% glycerol, 2 millimol/L DTT, 1 millimol/L ATP, pH 7.8)
and the rate of hydrolysis was monitored over 45 min. No enzymatic activity by IDE was
detected on chymotryptic-like (i.e., Suc-LLVY-AMC) and tryptic-like (i.e., Boc-LRR-AMC)
IDE Modulates the 26S Proteasome
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substrates (Figs A and B in S1 Fig). On the other hand, thr enzymatic activity by IDE on the
caspase-like (i.e., Z-LLE-AMC) substrate (Fig C in S1 Fig) was measured, allowing to obtain
the catalytic parameters according to the following equation:
½E0
v
¼ Km
kcat
 1½S þ
1
kcat
where [E0] is the enzyme concentration, ν is the observed velocity and [S] is the substrate con-
centration. The resulting catalytic parameter are Km, corresponding to the apparent afﬁnity
constant (or Michaelis-Menten constant) of substrate for the free enzyme (to form the ES com-
plex), and kcat, corresponding to the velocity of the rate-limiting step during the enzymatic
activity.
Western blotting analysis
Semi-quantitative analyses of IDE (Covance, Princeton, NJ, USA) and of the 26S proteasome,
HSP70, GAPDH and poly-ubiquitinated proteins (Abcam, Cambridge, UK) were performed
by Western blotting. The antibody to the 26S proteasome recognizes the p27 subunit of the
complex.
20 μg of proteins from crude cell extract or whole cell lysates were separated on a 10%
acrylamide gel under reducing and denaturing conditions. Separated proteins were then trans-
ferred to a HyBond-ECL nitrocellulose filters (Amersham Biosciences, Piscataway, NJ, USA)
for 1 h at 4°C. Unsaturated binding sites were blocked by incubating filters in a 0.01% Tween-
PBS, 5% fatty free milk solution. Filters were then probed with the specific antibody at the rec-
ommended concentration and, thereafter, incubated with a Horseradish Peroxidase-conju-
gated anti-rabbit or anti-mouse IgG antibody (Biorad, Hercules, CA, USA), diluted 1:50000 in
0.2% Tween-PBS fat-free milk. Immunoreactive signals were detected with an ECL Advance
Western Blotting Detection Kit (Amersham Biosciences).
Immunofluorescence and Confocal Microscopy
SHSY5Y cells were grown in high-glucose DMEM supplemented with 10% FBS, L-glutammine
(2 mM), penicillin (50 IU/ml), streptomycin (50 microg/ml), sodium pyruvate (1 millimol/L).
24 h after heat-stress administration (46°C, 20 min), control (not-stressed) and stressed
SHSY5Y cells were rinsed in phosphate buffered saline (PBS) and directly fixed in 4% (w/v)
paraformaldehyde for 15 min at room temperature. The fixed cells were blocked and permeabi-
lized with 3% (w/v) bovine serum albumin and 0.2% (v/v) Triton X-100 in PBS (blocking solu-
tion) for 20 min. For immunostaining, cells were incubated for 1 h with an anti-IDE rabbit
polyclonal antibody (Covance, Princeton, NJ, USA) together with either the anti-P26S or anti-
Na+/K+ATPase mouse monoclonal antibodies (Abcam, Cambridge, UK). Slides were also incu-
bated with an anti-IDE mouse monoclonal antibody (Covance, Princeton, NJ, USA), together
with either anti-Giantin or anti-calnexin rabbit polyclonal antibodies (respectively, Golgi and
ER Markers, Abcam, Cambridge, UK). After rinsing in PBS, cells were incubated with second-
ary antibodies, anti-rabbit conjugated with fluorescein isothiocyanate (FITC) (Vector Labora-
tories, USA) or conjugated with Alexa Fluor-633 (Invitrogen, USA) and anti-mouse
conjugated with Rhodamine Red or FITC (Invitrogen, USA), diluted in blocking solution for
1 h at room temperature. Cells were washed with PBS and nuclei counterstained with DAPI
(Sigma-Aldrich St Louis, CO). Images (1024x1024 pixel) of the cells were acquired sequentially
using a confocal laser scanning system (TCS-SP2, LeicaMicro-systems, GmbH, Wetzlar, Ger-
many, 63x/1.4 oil-immersion objective) with identical settings for laser power, gain and offset.
Images were analyzed with ImageJ program (http://rsbweb.nih.gov/ij/) and composed using
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Photoshop software (Adobe System, USA). Laser excitation at 488 nm of the sample was fol-
lowed by an excitation at 543 nm or 633 nm to collect emission signals from FITC and rhoda-
mine or Alexa Fluor-633, respectively. DAPI staining was imaged by two-photon excitation
(740 nm,< 140 fs, 90 MHz) performed with an ultrafast, tunable, mode-locked Ti: Sapphire
laser (Chameleon, Coherent Inc., Santa Clara, CA).
Co-Immunoprecipitation
An anti-IDE monoclonal antibody or not-specific mouse IgG, as internal control (Abcam,
Cambridge, UK) were coupled to M-270 epoxy Dynabeads (Invitrogen) as indicated by the
manufacturer (5 micrograms of Ab/1,5 milligrams of beads). Magnetic beads coated with anti-
IDE Ab were stored at 4°C in PBS, 0.02% NaN3. Before use, coated beads were washed three
times with lysis buffer. SHSY5Y cells were cultivated under standard conditions and heat-
stressed 20 min at 46°C. Total protein extracts were obtained by rinsing the cells twice with
ice-cold PBS followed by the addition of ice-cold lysis buffer (Co-IP), supplemented with
1 millimol/L DTT, 50 millimol/L NaCl and a protease-inhibitor cocktail with broad specificity
(Sigma-Aldrich St Louis, CO). Harvested cells were washed once in PBS and the pellet was
resuspended in the Extraction Buffer (cell mass to Extraction Buffer ratio 1:9) supplemented
with a protease inhibitor cocktail, according to manufacturer instruction (Invitrogen). Cells
were then incubated for 15 min in ice and centrifuged at 2600 x g for 5 min, 4°C. The extract
was used immediately for co-immunoprecipitation. Purification was achieved by slow mixing
at 4°C. The isolated protein complex was eluted from the beads for 20 min at room tempera-
ture in a fresh aqueous solution.
Subcellular Fractionation
Isolation of Endoplasmic Reticulum fraction from resting and heat-exposed SHSY5Y cells was
performed by following the method described elsewhere [51].
Briefly, SHSY5Y cells were grown under standard aerated conditions, heat-stressed and
recovered for 24 h. Afterwards, cells were harvested, resuspended in an isotonic buffer
(0.27 mol/L mannitol, 0.01 mol/L Tris-base, 100 millimol/L EDTA, 1 millimol/L PMSF, pH
7.4) and lysed through sonication. Cell lysates were then centrifuged 10 min at 1400 g, 4°C. A
small aliquot of the supernatant was then collected and labeled as total cell lysate.
The remaining supernatant was further centrifuged 10 min at 150,000 g at 4°C; the resulting
brown pellet (crude mitochondria) was then discarded. The crude ER (supernatant) was then
loaded on a sucrose gradient and centrifuged for 70 min at 152,000 g in an SW41 rotor at 4°C.
A small aliquot of the upper solution was then collected and labeled as cytosol, whereas the
white and dense band at the sucrose interface, representing the ER fraction, was carefully with-
drawn and diluted in the previously described isotonic buffer.
An additional centrifugation 45 min at 126,000 g at 4°C was performed to further purify
the ER fraction. The pellet was then resuspended in PBS 1x. Samples were then normalized
through Bradford assay and stored at -80°C until use. A mouse-polyclonal anti-calnexin anti-
body (Abcam, Cambridge, UK) was used to stain the ER fraction.
Limited tryptic digestion of ER fraction
The ER fraction purified either from resting cells or recovered cells (24 h of recovery) were
exposed to limited proteolytic digestion by 0.05% trypsin, supplemented with 1 millimol/L
EDTA, for 30 min at 30°C as described elsewhere [52]. As an internal control, samples were
incubated over the same time interval in the presence of 1 millimol/L EDTA and in the absence
of trypsin. Reaction was then blocked by adding standard sample buffer for electrophoresis and
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heat-denatured. Thereafter, the samples were run on SDS-PAGE and blotted to a nitrocellulose
membrane for Western blotting analysis. Filters were then probed with a polyclonal anti-IDE
antibody, an anti–calnexin (ER Marker) (Abcam, Cambridge, UK) and an anti-Erp57 (Santa-
Cruz, USA) rabbit polyclonal antibodies.
Purification of proteasome particles
Proteasome particles from the cytosolic fraction of SHSY5Y cells were affinity purified by
using a kit according to manufacturer instructions (Merck Millipore, Germany).
To improve proteasome stability along the purification procedure, the cytosolic fraction was
supplemented with 10% glycerol. Purified particles were then denatured and analyzed byWest-
ern blotting to get a semi-quantitative information on IDE association with 26S proteasome
under resting and heat-stress conditions.
It is worth pointing out that to maximize reliability of the experimental outcome, equal
amounts of cytosolic extract from the two experimental conditions were suspended with the
affinity beads. Furthermore, the purified proteasome pools were normalized by Bradford assay.
Statistical analysis
One-way analysis of variance (ANOVA) was used to assess statistically significant differences
among groups and Tukey’s honestly significant difference post hoc test was used for pairwise
comparisons after the analysis of variance.
Results
Proteasome activity in IDE-silenced neuroblastoma cells
We previously showed that IDE behaves as an Heat Shock Protein and that it co-purifies with
the 26S proteasome [22]. Further we demonstrated that, in SHSY5Y neuroblastoma cells,
extensive down-regulation of IDE expression (by administering 1 micromol/L IDE-targeting
siRNA) triggers apoptosis in association with a significant decrease in poly-ubiquitinated
(poly-Ub) proteins content [22].
In the present study, we first investigated the effect of a sub-lethal IDE siRNA dose (so as
to decrease IDE levels but avoiding apoptosis) on the modulation of the 26S proteasome activ-
ity and poly-Ub proteins turnover. To this purpose, 0.7 micromol/L IDE-targeting siRNA
(treated) was administered to SHSY5Y cells and their viability monitored over 96 h time period
after treatment; only a minimal decrease in the proliferation rate was detected (see Materials
and Methods) without a decrease in cell viability, which was always higher than 95%. As an
internal control, SHSY5Y cells were treated either with the siRNA vector alone (scrambled) or
else with a not-targeting pool of siRNA (mock). Notably, results from scrambled and mock
cells were fully comparable, as indicated in Figs 1 and 2: therefore, they will be not discussed
separately throughout the text below and they will be referred as wild-type cells.
Then, crude cell extracts (i.e. the soluble fraction of cells, obtained upon detergent-free
lysis procedure) [34,47,50] from each experimental condition were harvested 48 and 72 h after
anti-sense oligonucleotide delivery and investigations carried out through Western blotting
indicated that: (i) a limited reduction of intracellular IDE concentration in treated cells was
effectively obtained (i.e. 30% at 48 h and 50% at 72 h) (Fig 1A and 1B); (ii) no detectable varia-
tion in the overall content of 26S proteasome and GAPDH both in treated and wild-type cells
was occurring (Fig 1A).
Hence, a Western blotting analysis was set up to monitor the content in poly-ubiquitinated
proteins in the extracts. Fig 1C clearly indicates that, after 72 h from IDE-silencing, the limited
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down-regulation of IDE expression in treated cells (i.e., 50%) (Fig 1A and 1B) was enough to
get a significant reduction in poly-ubiquitinated proteins content in treated cells. The effect
was even less pronounced after 48 h from IDE-silencing (Fig 1C). Therefore, we concluded
that the phenomenon occurred regardless of apoptotic stimuli induction, suggesting a critical
contribution of IDE decrease.
Thereafter, to further investigate whether the observed behaviour depended on the
increased turn-over of poly-ubiquitinated proteins rather than the impaired synthesis, the
three enzymatic activities of the 26S proteasome were assayed employing the Suc-LLVY-MCA,
Boc-LRR-AMC and Z-LLE-AMC fluorogenic substrates, which are considered to be specific
for the chymotrpytic-like, tryptic-like and caspase-like activities, respectively. Interestingly, the
hydrolysis of 200 micromol/L of the three substrates by crude cell extracts from treated cells
displayed kinetics faster than that observed by extracts from wild-type cells (Fig 2). Further, the
behaviour seemed to be referable to the rate of IDE depletion, being maximally evident in sam-
ples harvested 72 h after siRNA delivery (Fig 2). In details, the kinetics of Suc-LLVY-AMC
hydrolysis (referable to the chymotryptic-like activity of 26S proteasome) showed a 15% and
50% increase after 48 h and 72 h of silencing, respectively (Fig 2A) in treated cells with respect
to wild-type cells. Similarly, the kinetics of Boc-LLR-AMC hydrolysis (referable to the tryptic-
like activity of 26S proteasome) were increased by 30% and 60% at 48 and 72 h, respectively
(Fig 2B), and the kinetics of Z-LLE-AMC (referable to the caspase-like activity of 26S protea-
some) were increased by 25% and 40% at 48 and 72 h, respectively (Fig 2C).
Fig 1. Western blotting analysis of crude cell extracts from treated (IDE-silenced) andwild-type
(scrambled andmock) SHSY5Y.Cell extracts were harvested 48 h and 72 h after the administration of 0.7
mircomol/L anti-sense oligonucleotides and analyzed throughWestern blotting. Filters were probed with
antibodies specific for IDE (110 kDa), P26S (22 kDa), GAPDH (37 kDa) and (C) poly-ubiquitinated proteins. A
representative immunoblot of five independent experiments is shown. (B) Densitometric analysis of IDE
signals from theWestern blotting is shown in Fig 1A.
doi:10.1371/journal.pone.0132455.g001
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Enzymatic Characterization of IDE-26S proteasome Interaction
These results raised the question whether the up-regulation of the 26S proteasome activity in
IDE-silenced SHSY5Y occurred through mechanisms dependent on a direct IDE interaction
or, instead, through unknown pathways indirectly linked to IDE-depletion.
To address this issue, and to get a mechanistic insight on IDE effect on the proteasome
activity, a biochemical study by using a highly purified preparations of 26S proteasome and
eukaryotic IDE was carried out. The kinetics of degradation of 50 micromol/L fluorogenic sub-
strates (i.e., Suc-LLVY-AMC, Boc-LLRAMC and Z-LLE-AMC for the chymotryptic, tryptic
and caspase-like activities, respectively) by 1 nanomol/L 26S proteasome, in standard activity
buffer at 37°C, in the presence of IDE concentrations ranging from 1 nanomol/L to 50 nano-
mol/L are reported in Fig 3.
Through these fluorimetric analyses, a consistent dose-dependent inhibition of the three
enzymatic activities of the 26S proteasome in the presence of IDE was observed, at least over
the investigated concentration range. In detail, in the presence of 50 nanomol/L IDE, the kinet-
ics of Suc-LLVY-AMC degradation was slowed down by 55% (Fig 3A), whereas, the kinetics of
Boc-LLR-AMC cleavage was reduced by 65–70% (Fig 3B); the reported values were referred to
the activity observed for the 26S proteasome alone under the same experimental conditions. It
must be outlined that the activity observed was highly specific for the 26S proteasome, since
the reaction was blocked exclusively upon administration of proteasome specific inhibitors
(i.e., 20 μM lactacystin and/or epoxomycin) and IDE alone did not show any enzymatic activity
on the Suc-LLVY-AMC and Boc-LLR-AMC fluorogenic substrates (S1A and S1B Fig).
Conversely, in the case of the caspase-like activity some additional considerations are
required, sinceIDE was found to be able to cleave the fluorogenic Z-LLE-AMC substrate in
vitro under this experimental condition (calculated kcat/KM = 1.93 x 10
2 M-1s-1) (S1C Fig).
Fig 2. 26S proteasome activity in crude cell extracts from treated andwild-type SHSY5Y. The
proteasome assay on crude cell extracts from either treated orwild-type cells was performed 48 h and 72 h
after the anti-sense oligonucleotide delivery. The chymotryptic-like (A), the tryptic-like (B) and the caspase-
like (C) activities of the 26S proteasome particles were assayed on specific fluorogenic substrates. Values
reported are the means +/- S.E. of five independent experiments. *, significantly different from control
(p<0.05, one way ANOVA, followed by Tukey’s test, n = 15).
doi:10.1371/journal.pone.0132455.g002
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Therefore, the caspase-like activity specific for the 26S proteasome was derived by subtracting
the enzymatic kinetics (moles/min) obtained from IDE alone at various concentrations, from
the catalytic activity of the 26S proteasome observed in the presence of the same IDE concen-
trations. The relative 26S proteasome activity dependence on IDE concentration, reported in
Fig 3C, corresponds to that obtained after this normalization and it clearly indicates that kinet-
ics of Z-LLE-AMC degradation by 1 nanomol/L 26S proteasome underwent 60% inhibition in
the presence of 50 nanomol/L IDE.
Furthemore, it is noteworthy that the modulation of the 26S proteasome activity by IDE,
reported in Fig 3A and 3C, could be also obtained when IDE had been previously incubated
with a Zn2+ chelator (i.e., EDTA), which inhibits IDE enzymatic activity for its fluorogenic sub-
strate (S2 Fig). This result indeed suggests that also enzymatically inactive IDE is able to affect
the 26S proteasome activity.
Time-Course of 26S proteasome activity over 24 h of recovery after
heat-stress in IDE-silenced and wild-type cells
It is widely recognized that the UPS plays a critical role during the Heat Shock Response, even
though the modulation of the 26S proteasome activity and the expression of the different sub-
units greatlyvaries depending on the type and the intensity of the stress and also on the cell
model investigated, likely reflecting the crowdness of UPS modulator in the intracellular com-
partment [36,53–56]. In this respect, the evidence that IDE metabolism is affected by stress and
the above described effect on the 26S proteasome activity envisaged a tight contribution of the
IDE-26S proteasome interaction to the HSR.
Since some authors previously described some physiological situation wherefore the IDE-
26S proteasome interaction was lost [48,49], we first checked whether in heat-stressed SHSY5Y
cells the interaction still occurred. Thus, confocal microscopy and co-immunoprecipitation
Fig 3. Biochemical characterization of IDE-26S proteasome interaction. The chymotriptic-like (A),
tryptic-like (B) and caspase-like (C) activities of a highly purified 26S proteasome were assayed on specific
fluorogenic substrates in presence of highly purified eukaryotic IDE. The reported values represent the ratio
between the velocity of degradation of 50 micromol/L fluorogenic substrate by 1 nM 26S in the absence and
the presence of different IDE concentrations, ranging from 10 nanomol/L to 50 nanomol/L. Results presented
are the means +/- S.E. of five independent experiments.
doi:10.1371/journal.pone.0132455.g003
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assay on resting and heat-stressed SHSY5Y demonstrated that IDE and the 26S proteasome dif-
fusely co-localized and co-immunoprecipitated in both experimental conditions (S3 Fig)
Therefore, a comparison between the activity of proteasome particles from wild-type and
IDE-silenced SHSY5Y cells during the HSR was performed. Noteworthy, IDE-silencing was
carried out by following the non-lethal conditions indicated above, whereas the heat-stress
(i.e., 46°C for 20 min) was administered 48 h after siRNA delivery. Since the 26S proteasome
activity from scrambled and mock cells was fully comparable, even in this case, these two
experimental conditions will not be discussed separately throughout the following text and
they will be referred to as wild-type cells.
Kinetics of Suc-LLVY-AMC degradation by 26S proteasome particles from wild-type cells
dramatically varied over the recovery phases: at time 0 of heat-stress recovery, the kinetics of
substrate cleavage was fully comparable to that of untreated cells (not-stressed). However,
within the first two hours, the 26S proteasome activity underwent progressive and consistent
down-regulation, by reaching about 45% (SD ± 5%) of the original activity (Fig 4A). Thereafter,
the activity slowly recovered, being, instead, consistently enhanced after 24 h of recovery with
respect to 26S proteasome particles extracted from untreated cells grown over the same time-
lapse under standard conditions.
Interestingly, such a pattern of 26S proteasome activity was lost in samples from IDE-
silenced SHSY5Y (Fig 4A). The kinetics of Suc-LLVY-AMC cleavage, recorded at various time-
points during the stress recovery, were substantially unaffected: thus, Fig 4A highlights the
“flattened” profile of the proteasome activity behaviour in IDE-silenced SHSY5Y cells, even
though a minimal decrease during the first phase was observed. Notably, the exogenous addi-
tion of tailored concentrations of eukaryotic IDE (10–40 nanomol/L) to the crude cell extracts
from IDE-silenced cells before the administration of the fluorogenic substrate were sufficient
to restore the original pattern of the activity during the HSR (Fig 4A). This approach was
accompanied, as an internal control, by a semi-quantitative analysis of the 26S proteasome,
HSP-70 and GAPDH contents in the crude cell extracts (Fig 4B), and no significant variation
between wild-type and IDE-silenced cells was observed. Thus, the relative abundance of the
26S proteasome and GAPDH was unaffected during the 24 h of recovery, whereas the HSP70
was markedly induced. Then, poly-ubiquitinated proteins content was analyzed and, even in
this case, no variations between wild-type and IDE-silenced cells was observed (Fig 4C). In
detail, even though in IDE-silenced cells a reduced basal content under resting conditions (i.e.
time 0) was confirmed to occur, consistently with our previous publication and with Fig 1C
[22], a dramatic decrease of the poly-Ub proteins was detected during the first 6 h of recovery
for both wild-type and IDE-silenced cells (Fig 4C). At later times (12 h) a significant accumula-
tion in poly-Ub was then documented for both wild-type and IDE-silenced cells, followed by a
recovery of its original content (after 24 h) (Fig 4C).
IDE distribution in the cell during the HSR
In our previous paper we demonstrated that IDE expression increased in whole cell lysate
upon stress exposure [22]; herewith, we focused instead our attention on the same crude cell
extracts (i.e. the soluble fraction of cells, obtained upon detergent-free lysis procedure) where
measurements of the 26S proteasome activity were undertaken. Through semi-quantitative
analysis by Western blotting, we observed the occurrence of a significant and progressive
reduction in IDE content in the cytosol under stressful conditions, being maximal after 24 h of
recovery (Fig 4B). Nonetheless, the observed behaviour was markedly less pronounced in IDE-
silenced cells. At this stage, it is not possible yet to provide a reliable and exhaustive interpreta-
tion of this behaviour. Indeed, data on wild-type cells, indeed, clearly indicated that IDE
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Fig 4. Time-course of 26S proteasome activity over the HSR andWestern blotting analyses. (A) The
chymotryptic-like activity of 26S proteasome particles partially purified fromwild-type (black square), treated
(red circle) and in presence of 10–40 nanomol/L exogenous IDE added to extracts from treated cells (green
triangle), was assayed through the proteasome assay: the relative activity represents the ratio between the
velocity of degradation of 200 micromol/L fluorogenic substrate at time 0 (resting conditions) vs the indicated
time of recovery. The reaction was followed over 3 h of incubation at 37°C. Results presented are the means
+/- S.E. of five independent experiments* (p<0.05, one way ANOVA, followed by Tukey’s test, n = 15).
Western blotting analysis of crude cell extracts: (B) Filters were probed with antibodies specific for: IDE (110
kDa), 26S proteasome (22 kDa), HSP70 (70 kDa), GAPDH (37 kDa). (C) Filters were probed with a
polyclonal antibody specific for ubiquitin. A representative immunoblot of five independent experiments is
shown.
doi:10.1371/journal.pone.0132455.g004
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content in the cytosol underwent a decrease during the HSR, in spite of an enhancement of the
overall IDE cellular content; this observation suggested a translocation of IDE from the cyto-
solic fraction to some other cell compartments which were excluded from crude cell extract
preparation. This suggestion was further reinforced by the evidence that IDE was accumulated
in the membrane-enriched cell pellets which were discarded during crude cell extracts prepara-
tion (S4 Fig). In order to confirm that the reduced cytosolic content of IDE in heat-stressed
SHSY5Y was mirrored by IDE accumulation in specific cell compartments, an immunofluores-
cence labelling of IDE in stressed and control wild-type SHSY5Y cells 24 h after heat adminis-
tration was carried out, by using different subcellular markers. In particular, (a) calnexin was
used to stain the endoplasmic reticulum (ER), (b) the anti-giantin antibody was employed to
identify components of the cis and medial Golgi system, (c) the Na+/K+ ATPase to stain the cell
membrane and (d) DAPI to label the nucleus. Interestingly, IDE redistribution occurred during
the HSR from the cytosol toward the ER with ER signals markedly increasing in heat-stressed
cells (Fig 5A). On the other hand, no localization of IDE in the Golgi was observed neither in
control nor in stressed SHSY5Y cells (Fig 5B); further, under our control and stressful condi-
tions, no translocation of IDE was detected neither toward the plasma membrane (Fig 5C) nor
to the nucleus (Fig 5A and 5B).
To further strengthen this evidence, sub-cellular fractionation assays were performed in
resting and heat-stressed SHSY5Y. Total lysates, ER fraction and cytosolic fraction were then
purified and assayed through Western blotting to get semi-quantitative insights on IDE con-
tent. Fig 6A clearly indicates that in the total lysate IDE expression increased with respect to
resting cells after 24 h of recovery from heat stress, consistently with results reported in our
previous paper [22]. Analysis on the purified cytosolic fraction (Fig 6A) further reinforced the
evidence that heat-exposition brought about a decrease in IDE, similarly to what observed in
crude cell extracts (Fig 4B). Then, the analysis in the ER fraction (Fig 6A), highlighted a consis-
tent accumulation of IDE at 24 h of recovery from heat-stress, thus confirming the confocal
microscopy outcome (Fig 5A). Moreover, filters were probed with an anti-calnexin antibody to
specifically stain the ER fraction and, as expected, the analysis revealed that the ER marker was
abundantly represented exclusively in the ER fraction, with minimal contamination of the
cytosolic fraction (Fig 6A).
Thereafter, to get some preliminary insights on the localization of IDE in the endoplasmic
reticulum i.e. endoluminal or at the cytosolic interface, a limited proteolysis by trypsin of the
ER fraction was performed. To this purpose, an aliquot of ER fractions from resting and heat-
stressed cells at 24 h of recovery, when a peak in IDE accumulation in such a compartment was
observed (Fig 6A), were incubated either with 0.05% trypsin supplemented with 1 mmol/L
EDTA or with 1 mmol/L EDTA alone, as an internal control. Then, samples were harvested at
the end of the reaction and analyzed by Western blotting to address the IDE accessibility to
proteolytic cleavage.
Fig 6B clearly indicates that upon trypsin treatment IDE undergoes proteolytic cleavage
with the appearance of several lower molecular weight fragments (100–65 kDa). Furthermore,
the effect appeared to be more pronounced in fraction from stressed cells, even though this
behaviour might simply reflect a relatively higher abundance of IDE under such experimental
conditions.
Antibodies directed against the luminal domain of calnexin, an ER transmembrane protein,
and Erp57, an endoluminal protein, were used as positive and negative control respectively. As
expected, digestion of ER fractions revealed a70 kDa proteinase-resistant fragment corre-
sponding to calnexin deprived of its cytosolic domain whereas Erp57 was fully resistant to tryp-
sin digestion (Fig 6B).
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Decreased IDE-proteasome interaction during the HSR
The bulk of data previously discussed suggest that IDE might represent a macromolecular
inhibitor of 26S proteasome activity. Further, we report that, during the HSR, the activity of the
cytosolic pool of 26S proteasome is progressively rescued by the cell: interestingly, a maximum
recovery is achieved at a time-point (i.e., 24 h) when IDE content is significantly decreased in
the cytosol (Fig 4A), being gathered in the outer face of the ER (Figs 5 and 6).
Fig 5. Confocal images of control and stressed fixed SHSY5Y cells 24 h after heat administration. Cell
localization of IDE was determined using anti-IDE mouse monoclonal (A and B) or anti-IDE rabbit polyclonal
(C) antibodies. The Endoplasmic Reticulum was stained with anti-calnexin (A), while Golgi was labelled with
anti-giantin rabbit polyclonal antibody (B). Plasmamembrane was stained with anti-Na+/ K+-ATPase mouse
monoclonal antibody (C) Nuclei were counterstained with DAPI (blue)(A,B). Bars correspond to 20
micrometers.
doi:10.1371/journal.pone.0132455.g005
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Hence, we wondered whether the greater activity of the 26S proteasome from heat stressed
cells at this time point might follow a decreased extent of binding by IDE and, thus, a reduced
inhibition.
To address this task, proteasome particles from the cytosolic fraction of resting and heat
stressed SHSY5Y (at 24 h of recovery) were affinity purified and analyzed by Western blotting
to get a semi-quantitative comparison of the amount of IDE bound to the proteasome.
Fig 7 indicates that proteasome particles purified from heat stressed cells display a several
fold lower content in IDE with respect to that purified from resting cells. As expected, no puri-
fication of proteasome is obtained by using not-specific beads, and equal quantities of purified
proteasome were loaded into the gel. Staining of inputs lanes clearly confirm that no variation
Fig 6. Analysis of IDE content in sub-cellular fractions and limited tryptic digestion of ER fractions. (A)
Total lysates, Endoplasmic Reticulum fraction and cytosolic fraction were separated from resting (referred to
as Ctrl) and stressed (referred to as Stress) SHSY5Y cells 24 h after heat administration and assayed by
Western blotting. Filters were probed either with a anti-IDE (110 kDa) or a anti-calnexin (67 kDa) antibodies.
(B) Endoplasmic Reticulum fractions from resting and stressed SHSY5Y were treated either with 0.05%
trypsin supplemented with 1 millimol/L EDTA (Trypsin) or with 1 millimol/L EDTA alone (Ctrl). Reaction
mixtures were then analyzed byWestern blotting. Filters were probed with a anti-IDE (110 kDa) polyclonal
antibody, with a anti-calnexin antibody (90 kDa) and with a anti-Erp57 antibody (57 kDa).
doi:10.1371/journal.pone.0132455.g006
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in the proteasome content is observed for the two experimental conditions, whereas a consis-
tent decrease of IDE in the cytosolic fraction is confirmed to occur.
Discussion
Herewith, by adopting different approaches, we report, for the first time, that the 26S protea-
some activity is significantly affected by variations in the intracellular distribution of IDE, thus
allowing to hypothesize that the IDE-proteasome interaction might represent a novel pathway
of regulation of intracellular proteolysis. Furthermore, these results strengthen the largely
envisaged notion that IDE biological role is of general significance, in accord with its evolution-
ary conservation and ubiquitous distribution. Notably, the results here reported are consistent
with several intriguing observations which have emerged over the last decade, namely: i) IDE
selects the substrates on the basis of their secondary/tertiary structure and targets amyloido-
genic proteins envisaging a role as “dead-end chaperone” [57]; ii) IDE binds to the ubiquitin
monomer [19,20]; iii) IDE processes sets of antigenic peptides for class I HLA presentation
[17]; iv) IDE regulates yeast proliferation under proteotoxic conditions [15]. The overall bulk
of data and the recently discussed HSP-like behaviour of IDE [22] would indeed account for its
widespread contribution to the Ubiquitin-Proteasome-System (USP) in regulating key aspects
of cell life.
Herewith we demonstrated that IDE down-regulation in SHSY5Y cells brings about an
increase in the proteolytic activity of the 26S proteasome (Fig 2) which is effective on fluoro-
genic substrates as well as on poly-ubiquitinated proteins.
Moreover, the IDE inhibitory effect on 26S proteasome was also confirmed by performing
an in vitro inhibition assay with the two purified macromolecular players (i.e. IDE and 26S pro-
teasome) (Fig 3). Furthermore, even though we cannot at this stage obtain a deeper informa-
tion on the equilibrium properties regulating this interaction, the observation that IDE
silencing brings about an effect closely similar to that corresponding to a lowering of IDE
Fig 7. Decreased IDE-proteasome interaction during the HSR. A semi-quantitative comparison of IDE
association with the proteasome by Western blotting. Membranes were stained with an anti-IDE antibody
(upper panel) and with an anti-protesaome (p27 subunit) antibody (lower panel). Input, stands for 5
micrograms of cytosolic extract loaded in the gel, whereas Ctrl stands for incubation of cell lysates with non-
specific beads. A representative immunoblot of three independent experiment is shown. Proteasome
particles from the cytosolic fraction of resting and heat-stressed SHSY5Y were affinity purified. Notably, a
lower molecular weight species is recognized by the anti-IDE antiboby. Anyway, we are unsure about the
identity of this band which, anyway, is constantly observed by us and by other authors when large amount of
cell extracts is loaded.
doi:10.1371/journal.pone.0132455.g007
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concentration in enzymatic assays (Figs 2 and 3) indeed suggests that the IDE-26S proteasome
complex is reversible with a very high affinity.
It is interesting to outline that the absence of insulin in our cellular cell silencing system
rules out that the observed effects could be referable to insulin or insulin fragments produced
by IDE catalysis, which were reported to modulate proteasome activity [48,49]. Therefore, we
believe that a major novelty element, which emerges from the analyses herewith discussed, is
that IDE could represent a critical 26S proteasome regulator even in absence of its substrates.
Intriguingly, preliminary results suggest the possibility that the IDE-dependent modulation of
the 26S proteasome activity might occur through extra-catalytic mechanisms, rendering of
great interest further investigations on the mechanistic insights of the interaction.
Moreover, the novel observation that IDE efficiently degrades the Z-LLE-AMC fluorogenic
substrate, considered to be specific for the caspase-like activity of the proteasome, raises the
question of a careful consideration when assessing the 26S proteasome caspase-like proteolysis
rate.
On the basis of the recently discussed HSP-like behaviour of IDE [22], we can then formu-
late the reasonable hypothesis that the IDE-26S proteasome functional interaction should be
critical also during the HSR.
In fact, our results demonstrate that during the HSR, the ordered and chronologically
defined pattern of activity of cytosolic 26S proteasome particles observed in wild-type SHSY5Y
(which is consistent with data from other authors, see refs. [38,47]) was lost in IDE-depleted
and stressed cells, but rescued by the addition of tailored concentrations of exogenous IDE.
Interestingly, the overlapping behaviour of poly-ubiquitinated proteins between wild-type and
IDE-silenced cells (Fig 4) (with the exception of samples from unstressed cells, wherein a
minor content in the last conditions was confirmed to occur) along with the evidence that the
26S proteasome content does not vary either during the HSR or upon IDE-silencing (Fig 4)
(accordingly with the notion that deletion of the heat shock transcription factor (i.e. Hsf1) gene
does not impair proteasome expression in stressed cells [58]) allow to hypothesize that IDE
role could be restricted to the modulation of the 26S proteasome activity without affecting
pathways that are upstream to the proteolytic removal of its substrates. The intrinsic complex-
ity of the biological process, i.e. the HSR, the heterogeneity in proteasome subpopulations and
the bio-availability of modulators indeed represent critical topics in determining the observa-
tions herewith reported and IDE could be one of the player.
However, the evidence that the cytosolic 26S proteasome activity at later phases of the HSR
is rescued concurrently with a decreased interaction with IDE (Fig 7), likely determined by the
enzyme gathering at the outer surface of the ER (Figs 5 and 6), raises the intriguing perspective,
which can be only considered a working hypothesis at this stage, that the inhibitory role of IDE
might be a tightly controlled pathway for the regulation of the overall proteasome activity and
intracellular homeostasis.
In addition, it seems to come out that IDE migration to the ER during the HSR is a relevant
aspect of the physiological role played by this ubiquitous enzyme in the regulation of cellular
homeostasis. Notably, previously reported RT-PCR results clearly indicated that IDE transcrip-
tion is quickly triggered upon stress exposure, turning back to basal levels within 5 h of HSR
[22]: this observation appears to rule out the hypothesis that ER accumulation of IDE relies
exclusively in de novo synthesis of the enzyme, leading instead to strengthen the idea that post-
traslational modification or interaction with a still unknown molecular player might actually
take place.
In conclusion, our work provides novel insight into the modulatory role of IDE on the enzy-
matic activities of the 26S proteasome. Notably, the regulation takes place even at nanomolar
IDE concentrations and it appears reversible, as indicated by the reverse effect induced by IDE
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silencing, suggesting that it could represent a novel critical pathway of intracellular proteolysis
regulation.
Supporting Information
S1 Fig. IDE effect on the Suc-LLVY-AMC, Boc-LLR-AMC and Z-LLE-AMC fluorogenic
substrates. (A) 50 micromol/L Suc-LLVY-AMC and (B) 50 micromol/L Boc-LLR-AMC, spe-
cific for chymotryptic-like and the tryptic-like activity of the 26S proteasome, respectively,
were incubated in the presence of 30 nM IDE in the 26S assay buffer (20 millimol/L Tris-HCl,
10 millimol/L MgCl2, 10% glycerol, 2 millimol/L DTT, 1 millimol/L ATP, pH 7.8). IDE does
not cleave these fluorogenic substrates. A representative experiment is shown (C). Double
reciprocal plots of Z-LLE-AMC degradation by IDE. The fluorogenic substrate was incubated
in the presence of 30 nanomol/L IDE in the 26S assay buffer and catalytic parameters were cal-
culated and reported in this work. Results presented are the means +/- S.E. of three indepen-
dent experiments.
(DOC)
S2 Fig. IDE effect on 26S activity in the presence of EDTA. 7.5 picomoles of IDE were
incubated 45 min at 37°C in the presence of 5 millimol/L EDTA to get full inactivation of the
enzyme. Thereafter, the reaction volume was diluted in the assay buffer (20 millimol/L Tris-
HCl, 10 millimol/L MgCl2, 10% glycerol, 2 millimol/L DTT, 1 millimol/LM ATP, pH 7.8)
contatining 1 nanomol/L 26S proteasome. After dilution IDE concentration was 30 nanomol/
L. The reaction mixture was, then, incubated 20 min at 37°C. Finally 50 micromol/L Suc-
LLVY-AMC was added and the rate of hydrolysis of the fluorogenic substrate was monitored.
As internal control the activity of the 26S proteasome alone was recorded in presence of
EDTA.The final concentration of EDTA in the reaction mixtures for the 26S proteasome in
presence and absence of IDE were identical. As shown, the modulator effect of IDE on protea-
some activity is detected also in the presence of EDTA. 26 S proteasome (—–); 26S proteasome
in presence of EDTA (—–); 26S proteasome + 30 nanomol/L IDE (—–); 26S proteasome + 30
nanomol/L IDE in presence of EDTA (—–).
(DOC)
S3 Fig. Analysis of IDE-26S proteasome association through Confocal Microscopy and
Immuno-Precipitation. (A) Control and heat-stressed fixed SHSY5Y cells were co-stained
with anti-IDE and anti-26S proteasome antibodies followed by fluorescein anti-rabbit (green)
and rhodamine-red X anti-mouse (red) secondary antibodies. Merged images show a diffuse
cytosolic co-localization of IDE and 26S proteasome both in control and in stressed cells. West-
ern blotting analysis of co-immunoprecipitates from heat-stressed (B) and resting (C) SHSY5Y
reveal the association of IDE with the 26S proteasome. No detectable level of IDE and 26S pro-
teasome were obtained upon co-immunoprecipitation with non-specific IgG. It is noteworthy
that result shown in panel C is in apparent contradiction with that of Fig 7. Anyway, it has to
be considered that the Co-IP experiment was performed on a whole lysate. Then we hypothe-
size that upon dissolution of the ER, IDE is readily available for again binding to the protea-
some, an event which is likely to occur also considering the apparent very high affinity for the
complex formation.
(DOC)
S4 Fig. Semi-quantitative analysis of IDE in the pellet fraction. The membrane-enriched pel-
let separated during crude cell extracts preparation (those discussed in Fig 5B) from wild type
and IDE-silenced SHSY5Y cells were dissolved in standard lysis buffer supplemented with 1%
Triton. The protein concentration was normalized through Bradford assay. A Western blotting
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analysis was then performed and filters were probed with a polyclonal anti-IDE antibody. As
internal control filters were probed with a anti-Na+/K+ ATP-ase.
(DOC)
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